首页 > 最新文献

Journal of Nephropharmacology最新文献

英文 中文
Evaluating risk factors for catheter-related infections in hemodialysis patients 血液透析患者导管相关感染的危险因素评估
Q3 Medicine Pub Date : 2022-06-09 DOI: 10.34172/npj.2022.10489
S. Hajian, M. Seifzade
Introduction: Catheter-related infection in the patients with end-stage renal disease (ESRD) is one of the leading causes of death. Identifying risk factors for infection, including patients’ iron profile, plays an important role in preventing this complication. Objectives: In this study, we aimed to determine the risk factors of catheter-related infections among the ESRD patients in Qazvin, Iran. Patients and Methods: In this observational study, 41 patients with hemodialysis venous catheter-related infection (case group) and 42 patients without catheter-related infection ( control group) in Qazvin educational and medical centers were studied. The definition of functional iron deficiency anemia included ferritin <500 ng/mL and serum iron/total iron-binding capacity (TIBC) <30%. The laboratory evaluation method was based on enzyme-linked immunosorbent assay method. Definition of catheter-related infection in this study consisted of two positive results of the three cultures from blue and red catheter lines and blood at the same time with the same microorganism. Results: In studying iron parameters, a significant difference between serum iron levels and transferrin saturation in the two groups was detected (P values of 0.0016 and 0.003, respectively). Both parameters were higher in the control group. The most common microorganism causing the infection was Staphylococcus aureus (43.9%) and most of the catheters used were of temporary internal jugular vein types. The most important risk factors in the incidence of catheter infection were diabetes mellitus (OR = 5.059) and high serum iron levels (OR = 1.053). Decreased transferrin saturation levels reduced the risk of infection (OR = 0.825). Conclusion: There was a relationship between iron profile and diabetes mellitus and the increased risk of catheter-related infections. To prevent infection, patients with ESRD undergoing hemodialysis with venous catheters, blood sugar and serum iron levels need to be monitored carefully and iron overdose should be prevented in these patients.
引言:终末期肾病(ESRD)患者的导管相关感染是导致死亡的主要原因之一。识别感染的危险因素,包括患者的铁谱,对预防这种并发症起着重要作用。目的:在本研究中,我们旨在确定伊朗Qazvin ESRD患者中导管相关感染的危险因素。患者和方法:在这项观察性研究中,对Qazvin教育和医疗中心的41名血液透析静脉导管相关感染患者(病例组)和42名无导管相关感染的患者(对照组)进行了研究。功能性缺铁性贫血的定义包括铁蛋白<500 ng/mL和血清铁/总铁结合能力(TIBC)<30%。实验室评价方法以酶联免疫吸附测定法为基础。在本研究中,导管相关感染的定义包括来自蓝色和红色导管线的三种培养物和血液的两个阳性结果,同时使用相同的微生物。结果:在研究铁参数时,两组的血清铁水平和转铁蛋白饱和度之间存在显著差异(P值分别为0.0016和0.003)。两个参数在对照组中均较高。引起感染的最常见微生物是金黄色葡萄球菌(43.9%),大多数使用的导管是临时颈内静脉型。导管感染发生率的最重要危险因素是糖尿病(OR=5.059)和高血清铁水平(OR=1.053)。转铁蛋白饱和水平降低可降低感染风险(OR=0.825)。结论:铁谱与糖尿病和导管相关感染风险增加之间存在关系。为了预防感染,需要仔细监测使用静脉导管进行血液透析的ESRD患者的血糖和血清铁水平,并防止这些患者铁过量。
{"title":"Evaluating risk factors for catheter-related infections in hemodialysis patients","authors":"S. Hajian, M. Seifzade","doi":"10.34172/npj.2022.10489","DOIUrl":"https://doi.org/10.34172/npj.2022.10489","url":null,"abstract":"Introduction: Catheter-related infection in the patients with end-stage renal disease (ESRD) is one of the leading causes of death. Identifying risk factors for infection, including patients’ iron profile, plays an important role in preventing this complication. Objectives: In this study, we aimed to determine the risk factors of catheter-related infections among the ESRD patients in Qazvin, Iran. Patients and Methods: In this observational study, 41 patients with hemodialysis venous catheter-related infection (case group) and 42 patients without catheter-related infection ( control group) in Qazvin educational and medical centers were studied. The definition of functional iron deficiency anemia included ferritin <500 ng/mL and serum iron/total iron-binding capacity (TIBC) <30%. The laboratory evaluation method was based on enzyme-linked immunosorbent assay method. Definition of catheter-related infection in this study consisted of two positive results of the three cultures from blue and red catheter lines and blood at the same time with the same microorganism. Results: In studying iron parameters, a significant difference between serum iron levels and transferrin saturation in the two groups was detected (P values of 0.0016 and 0.003, respectively). Both parameters were higher in the control group. The most common microorganism causing the infection was Staphylococcus aureus (43.9%) and most of the catheters used were of temporary internal jugular vein types. The most important risk factors in the incidence of catheter infection were diabetes mellitus (OR = 5.059) and high serum iron levels (OR = 1.053). Decreased transferrin saturation levels reduced the risk of infection (OR = 0.825). Conclusion: There was a relationship between iron profile and diabetes mellitus and the increased risk of catheter-related infections. To prevent infection, patients with ESRD undergoing hemodialysis with venous catheters, blood sugar and serum iron levels need to be monitored carefully and iron overdose should be prevented in these patients.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46714082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemodialysis catheter-related bloodstream infections: A single-centre experience 血液透析导管相关血流感染:单中心体验
Q3 Medicine Pub Date : 2022-05-31 DOI: 10.34172/npj.2022.10475
M. Bhojaraja, R. Prabhu, S. Nagaraju, I. Rao, S. Shenoy, Dhrshan Rangasamy, V. Krishna, M. Nayak
Aim and objectives: In hemodialysis patients, catheter-related bloodstream infections (CRBSI) cause significant morbidity and mortality. We analyzed CRBSI incidence, associated factors, and the causative organisms’ spectrum. Methodology: Patients aged ≥18 years either on maintenance hemodialysis or with acute kidney injury having CRBSI (NKF-KDOQI criteria) were included in this prospective observational study and patients with other infections were excluded. Blood, catheter tip culture and antibiogram were analyzed. All patients were initially treated with antibiotics covering both gram-positive and gram-negative pathogens. Results: Of 921 catheters (882 patients) analyzed, 212 (23%) had CRBSI, of which 69(32.5%) and 143(67.5%) had possible CRBSI and probable CRBSI respectively. 131 (61.8%) were <60 years, 133 (62.7%) were males, 177 (83.5%) had diabetes, 141(66.5%) had leukocytosis and 172(81.1%) had positive procalcitonin. 193 (91%) had uncuffed catheters and 162 (76.4%) had jugular catheters. Our study showed that CRBSI incidence was 13.39/1000 catheter days, median catheter days, and median time to CRBSI was 40 and 17.2 days. Gram-positive coagulase-negative staphylococcus aureus (n=31; 44.9%) followed by extended-spectrum beta-lactamase (ESBL) enteric gram-negative organisms (n=30; 43.4%) were common isolates and remaining had fungal etiology (n=8; 11.7%). Conclusion: The incidence of CRBSI was high in our population. In culture-positive cases, gram-positive organisms contributed marginally higher than gram-negative organisms. Coagulase Negative Staphylococcus aureus (CONS) and ESBL enteric gram-negative organisms are the commonest isolates. More than two-thirds of patients with CRBSI had diabetes mellitus and leukocytosis at presentation.
目的和目的:在血液透析患者中,导管相关性血流感染(CRBSI)导致显著的发病率和死亡率。我们分析了CRBSI的发病率、相关因素和致病微生物的谱。方法:年龄≥18岁的维护性血液透析患者或伴有CRBSI (NKF-KDOQI标准)的急性肾损伤患者纳入本前瞻性观察性研究,排除其他感染的患者。分析血液、导管尖端培养及抗生素谱。所有患者最初都使用抗生素治疗,包括革兰氏阳性和革兰氏阴性病原体。结果:921根导管(882例)中,发生CRBSI 212根(23%),其中可能发生CRBSI 69根(32.5%),可能发生CRBSI 143根(67.5%)。年龄<60岁131例(61.8%),男性133例(62.7%),糖尿病177例(83.5%),白细胞增多141例(66.5%),降钙素原阳性172例(81.1%)。193例(91%)使用无套管导管,162例(76.4%)使用颈静脉导管。我们的研究显示,CRBSI的发生率为13.39/1000导管天,中位导管天数和中位CRBSI时间分别为40天和17.2天。革兰氏阳性凝固酶阴性金黄色葡萄球菌(n=31;44.9%),其次是广谱β -内酰胺酶(ESBL)肠道革兰氏阴性菌(n=30;43.4%)常见分离株,其余为真菌病原学(n=8;11.7%)。结论:CRBSI在我国人群中发病率较高。在培养阳性病例中,革兰氏阳性菌的贡献略高于革兰氏阴性菌。凝固酶阴性金黄色葡萄球菌(con)和肠内革兰氏阴性菌ESBL是最常见的分离株。超过三分之二的CRBSI患者在发病时患有糖尿病和白细胞增多症。
{"title":"Hemodialysis catheter-related bloodstream infections: A single-centre experience","authors":"M. Bhojaraja, R. Prabhu, S. Nagaraju, I. Rao, S. Shenoy, Dhrshan Rangasamy, V. Krishna, M. Nayak","doi":"10.34172/npj.2022.10475","DOIUrl":"https://doi.org/10.34172/npj.2022.10475","url":null,"abstract":"Aim and objectives: In hemodialysis patients, catheter-related bloodstream infections (CRBSI) cause significant morbidity and mortality. We analyzed CRBSI incidence, associated factors, and the causative organisms’ spectrum. Methodology: Patients aged ≥18 years either on maintenance hemodialysis or with acute kidney injury having CRBSI (NKF-KDOQI criteria) were included in this prospective observational study and patients with other infections were excluded. Blood, catheter tip culture and antibiogram were analyzed. All patients were initially treated with antibiotics covering both gram-positive and gram-negative pathogens. Results: Of 921 catheters (882 patients) analyzed, 212 (23%) had CRBSI, of which 69(32.5%) and 143(67.5%) had possible CRBSI and probable CRBSI respectively. 131 (61.8%) were <60 years, 133 (62.7%) were males, 177 (83.5%) had diabetes, 141(66.5%) had leukocytosis and 172(81.1%) had positive procalcitonin. 193 (91%) had uncuffed catheters and 162 (76.4%) had jugular catheters. Our study showed that CRBSI incidence was 13.39/1000 catheter days, median catheter days, and median time to CRBSI was 40 and 17.2 days. Gram-positive coagulase-negative staphylococcus aureus (n=31; 44.9%) followed by extended-spectrum beta-lactamase (ESBL) enteric gram-negative organisms (n=30; 43.4%) were common isolates and remaining had fungal etiology (n=8; 11.7%). Conclusion: The incidence of CRBSI was high in our population. In culture-positive cases, gram-positive organisms contributed marginally higher than gram-negative organisms. Coagulase Negative Staphylococcus aureus (CONS) and ESBL enteric gram-negative organisms are the commonest isolates. More than two-thirds of patients with CRBSI had diabetes mellitus and leukocytosis at presentation.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43611999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute oxalate nephropathy associated with herbal remedies 与草药治疗相关的急性草酸肾病
Q3 Medicine Pub Date : 2022-04-24 DOI: 10.34172/npj.2022.10482
B. Bashardoust, M. Asgari
The use of herbal remedies has grown in recent years, largely due to their increased production and the media advertisements which target their use for the cure of almost all symptoms. Herbal remedies have also become popular in multi-plant forms and have recently become available in both industrial and condensed formulations, with higher doses being administered. We report a 68-year-old woman presenting with symptoms of flank pain, nausea, vomiting, anuria, and hematuria. She has history diabetes mellitus, hypertension and use of herbal including Achillea millefolium and Thymus migricus, Nasturtium for the last four months. Kidney biopsy was performed and was diagnosed with oxalate nephropathy. After the use of herbals was stopped, creatinine levels returned toward normal value in the following months with no complications. Herbal remedies would cause severe organ failures if administered in high-doses and should be considered as a possible cause in patients presenting with AKI.
近年来,草药的使用有所增加,这主要是由于它们的产量增加,以及媒体广告将其用于治疗几乎所有症状。草药疗法也以多种植物的形式流行起来,最近以工业和浓缩制剂的形式出现,并有更高的剂量。我们报告一位68岁的女性,其症状为腹痛、恶心、呕吐、无尿和血尿。她有糖尿病、高血压病史,并在过去四个月内使用了包括千叶阿昔洛韦和麝香草、Nasturtium在内的草药。肾活检被诊断为草酸肾病。停止使用草药后,肌酐水平在接下来的几个月内恢复到正常值,没有出现并发症。如果高剂量服用草药,会导致严重的器官衰竭,应将其视为AKI患者的可能原因。
{"title":"Acute oxalate nephropathy associated with herbal remedies","authors":"B. Bashardoust, M. Asgari","doi":"10.34172/npj.2022.10482","DOIUrl":"https://doi.org/10.34172/npj.2022.10482","url":null,"abstract":"The use of herbal remedies has grown in recent years, largely due to their increased production and the media advertisements which target their use for the cure of almost all symptoms. Herbal remedies have also become popular in multi-plant forms and have recently become available in both industrial and condensed formulations, with higher doses being administered. We report a 68-year-old woman presenting with symptoms of flank pain, nausea, vomiting, anuria, and hematuria. She has history diabetes mellitus, hypertension and use of herbal including Achillea millefolium and Thymus migricus, Nasturtium for the last four months. Kidney biopsy was performed and was diagnosed with oxalate nephropathy. After the use of herbals was stopped, creatinine levels returned toward normal value in the following months with no complications. Herbal remedies would cause severe organ failures if administered in high-doses and should be considered as a possible cause in patients presenting with AKI.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44513965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Comparison of creatinine based glomerular filtration rate estimation equations in voluntary Indian kidney donors: A single centre study" “印度自愿肾脏捐献者基于肌酐的肾小球滤过率估计方程的比较:一项单中心研究”
Q3 Medicine Pub Date : 2022-04-24 DOI: 10.34172/npj.2022.10443
S. Nagaraju, Kosuru Srinivas, M. Bhojaraja, S. Shenoy, I. Rao, R. Prabhu, D. Rangaswamy, V. Guddattu, V. Krishna, M. Nayak
Aim: In transplantation, accurate donor glomerular filtration rate (GFR) estimation is crucial. While various creatinine based equations are in use, none are validated in Indians, thus this study was conducted to judge accuracy of creatinine based GFR estimation equations and urinary creatinine clearance. Methods: A single-centre, observational and retrospective study at a tertiary care hospital. Adult voluntary donors GFR measured (mGFR) by Tc‑99m DTPA were included. Primary outcome was performance of estimated GFR (eGFR) by Cockcroft-Gault's formula corrected for body surface area (CG-BSA), Modification of diet in renal disease (MDRD) 4/6 and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI); Secondary outcome was performance of 24 hour urinary creatinine clearance (Cr Cl). Results: 102 kidney donors were analysed with mean age of 45.89 ± 9.98 years and 85.3% females. Mean ± SD mGFR by Tc‑99m DTPA was 82.11 ± 14.32 ml/min/1.73m2. Mean ± SD eGFR (ml/min/1.73m2) by CG-BSA was 99.68 ± 23.71, by MDRD-4 was 98.25 ± 28.61, by MDRD-6 was 93.66 ± 19.44 and by CKD-EPI was 111.14 ± 31.61. Lowest bias (2.3), highest precision (16.23) and accuracy (97.1%) was with MDRD-6; 24-hour urinary Cr Cl highly overestimated GFR (158.27 ml/min/1.73 m2) with highest bias, lowest precision and accuracy. Conclusion: Among the equations, MDRD-6 was the most precise and accurate with 24 hour urinary creatinine clearance being the least reliable. This study highlights the need for a correction factor or a new GFR estimation equation and not to consider urinary Cr Cl to assess donor GFR.
目的:在移植中,准确估计供体肾小球滤过率(GFR)是至关重要的。虽然使用了各种基于肌酸酐的方程,但没有一个在印度人中得到验证,因此本研究旨在判断基于肌酸酐GFR估计方程和尿肌酐清除率的准确性。方法:在一家三级护理医院进行单中心、观察性和回顾性研究。纳入了通过Tc-99m-DTPA测量的成人自愿捐献者GFR(mGFR)。主要结果是通过校正体表面积的Cockcroft-Gault公式(CG-BSA)、肾脏疾病饮食调整(MDRD)4/6和慢性肾脏疾病流行病学协作(CKD-EPI)估计的GFR(eGFR)的表现;次要结果是24小时尿肌酐清除率(Cr Cl)。结果:102名供肾者的平均年龄为45.89±9.98岁,女性占85.3%。Tc-99m-DTPA的平均±SD mGFR为82.11±14.32 ml/min/1.73m2。CG-BSA的平均±SD eGFR(ml/min/1.73m2)为99.68±23.71,MDRD-4为98.25±28.61,MDRD-6为93.66±19.44,CKD-EPI为111.14±31.61。MDRD-6的偏倚最低(2.3),精密度最高(16.23),准确度最高(97.1%);24小时尿Cr Cl高度高估GFR(158.27 ml/min/1.73 m2),偏差最高,精密度和准确度最低。结论:在这些方程中,MDRD-6是最精确和准确的,24小时尿肌酐清除率是最不可靠的。这项研究强调需要一个校正因子或一个新的GFR估计方程,而不是考虑尿Cr Cl来评估供体GFR。
{"title":"\"Comparison of creatinine based glomerular filtration rate estimation equations in voluntary Indian kidney donors: A single centre study\"","authors":"S. Nagaraju, Kosuru Srinivas, M. Bhojaraja, S. Shenoy, I. Rao, R. Prabhu, D. Rangaswamy, V. Guddattu, V. Krishna, M. Nayak","doi":"10.34172/npj.2022.10443","DOIUrl":"https://doi.org/10.34172/npj.2022.10443","url":null,"abstract":"Aim: In transplantation, accurate donor glomerular filtration rate (GFR) estimation is crucial. While various creatinine based equations are in use, none are validated in Indians, thus this study was conducted to judge accuracy of creatinine based GFR estimation equations and urinary creatinine clearance. Methods: A single-centre, observational and retrospective study at a tertiary care hospital. Adult voluntary donors GFR measured (mGFR) by Tc‑99m DTPA were included. Primary outcome was performance of estimated GFR (eGFR) by Cockcroft-Gault's formula corrected for body surface area (CG-BSA), Modification of diet in renal disease (MDRD) 4/6 and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI); Secondary outcome was performance of 24 hour urinary creatinine clearance (Cr Cl). Results: 102 kidney donors were analysed with mean age of 45.89 ± 9.98 years and 85.3% females. Mean ± SD mGFR by Tc‑99m DTPA was 82.11 ± 14.32 ml/min/1.73m2. Mean ± SD eGFR (ml/min/1.73m2) by CG-BSA was 99.68 ± 23.71, by MDRD-4 was 98.25 ± 28.61, by MDRD-6 was 93.66 ± 19.44 and by CKD-EPI was 111.14 ± 31.61. Lowest bias (2.3), highest precision (16.23) and accuracy (97.1%) was with MDRD-6; 24-hour urinary Cr Cl highly overestimated GFR (158.27 ml/min/1.73 m2) with highest bias, lowest precision and accuracy. Conclusion: Among the equations, MDRD-6 was the most precise and accurate with 24 hour urinary creatinine clearance being the least reliable. This study highlights the need for a correction factor or a new GFR estimation equation and not to consider urinary Cr Cl to assess donor GFR.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49302803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of glomerular filtration rate and fibroblast growth factor-23 levels in chronic kidney disease; sub analysis chronic kidney disease–mineral and bone disorder study 慢性肾脏疾病肾小球滤过率与成纤维细胞生长因子-23水平的相关性;亚分析慢性肾脏疾病&矿物质和骨骼障碍研究
Q3 Medicine Pub Date : 2022-04-24 DOI: 10.34172/npj.2022.10446
Akiko Syawalidhany Tahir, H. Rasyid, S. Bakri, H. Kasim, Tutik Harjianti, M. L. Parewangi, Harun Iskandar, A. Seweng, Resha Dermawansyah Rusman
Introduction: One of the chronic kidney disease (CKD) manifestations is mineral disorder, such as phosphate and calcium. Phosphatonin levels are regulated by the hormone phosphatonin, which the most commonly associated with CKD is fibroblast growth factor-23 (FGF-23), mainly synthesized by bone cells. The increase in FGF-23 in CKD subjects is a physiological response to stabilize phosphate levels. Several conditions can increase FGF-23 levels including age, body mass index (BMI), diabetes mellitus (DM), and hypertension. Objectives: This study aims to test the correlation between FGF-23 levels at various stages of glomerular filtration rate (GFR) in CKD. Patients and Methods: This study is observational with a cross-sectional approach conducted at Wahidin Sudirohusodo and Unhas hospitals of Makassar. Subjects are CKD patients which meet inclusion criteria. Intact serum FGF-23 levels were measured using an ELISA (enzyme-linked immunosorbent assay) kit (Immutopics). Statistical analysis was conducted using ANOVA test, Mann-Whitney U, and Spearman’s correlation tests. Statistical results are considered significant if P<0.05. Results: The research was conducted on 78 subjects with CKD stages 3, 4 and 5, which consisted of 40 men and 38 women. The correlation test showed that the lower the GFR, the higher the FGF-23 level (P<0.05). No significant correlation between age, body mass index, diabetes mellitus, and hypertension with FGF-23 were detected (P>0.05). Conclusion: We found that every increase in the CKD stages and decrease of GFR, would be associated with an increase in the plasma levels of FGF-23. However, FGF-23 plasma concentration had no significant correlation with age, BMI, DM, and hypertension.
引言:慢性肾脏疾病(CKD)的表现之一是矿物质紊乱,如磷酸盐和钙。磷酸酶水平受激素磷酸酶的调节,与CKD最常见的是成纤维细胞生长因子-23(FGF-23),主要由骨细胞合成。CKD受试者FGF-23的增加是稳定磷酸盐水平的生理反应。有几种情况会增加FGF-23水平,包括年龄、体重指数(BMI)、糖尿病(DM)和高血压。目的:本研究旨在测试CKD肾小球滤过率(GFR)不同阶段FGF-23水平之间的相关性。患者和方法:这项研究是观察性的,采用横断面方法,在望加锡的Wahidin Sudirohusodo和Unhas医院进行。受试者为符合纳入标准的CKD患者。使用ELISA(酶联免疫吸附测定)试剂盒(Imutopics)测量完整血清FGF-23水平。使用ANOVA检验、Mann-Whitney U和Spearman相关检验进行统计分析。结论:CKD分期的每增加一次,肾小球滤过率的每降低一次,都与血浆FGF-23水平的升高有关。然而,FGF-23血浆浓度与年龄、BMI、DM和高血压没有显著相关性。
{"title":"Correlation of glomerular filtration rate and fibroblast growth factor-23 levels in chronic kidney disease; sub analysis chronic kidney disease–mineral and bone disorder study","authors":"Akiko Syawalidhany Tahir, H. Rasyid, S. Bakri, H. Kasim, Tutik Harjianti, M. L. Parewangi, Harun Iskandar, A. Seweng, Resha Dermawansyah Rusman","doi":"10.34172/npj.2022.10446","DOIUrl":"https://doi.org/10.34172/npj.2022.10446","url":null,"abstract":"Introduction: One of the chronic kidney disease (CKD) manifestations is mineral disorder, such as phosphate and calcium. Phosphatonin levels are regulated by the hormone phosphatonin, which the most commonly associated with CKD is fibroblast growth factor-23 (FGF-23), mainly synthesized by bone cells. The increase in FGF-23 in CKD subjects is a physiological response to stabilize phosphate levels. Several conditions can increase FGF-23 levels including age, body mass index (BMI), diabetes mellitus (DM), and hypertension. Objectives: This study aims to test the correlation between FGF-23 levels at various stages of glomerular filtration rate (GFR) in CKD. Patients and Methods: This study is observational with a cross-sectional approach conducted at Wahidin Sudirohusodo and Unhas hospitals of Makassar. Subjects are CKD patients which meet inclusion criteria. Intact serum FGF-23 levels were measured using an ELISA (enzyme-linked immunosorbent assay) kit (Immutopics). Statistical analysis was conducted using ANOVA test, Mann-Whitney U, and Spearman’s correlation tests. Statistical results are considered significant if P<0.05. Results: The research was conducted on 78 subjects with CKD stages 3, 4 and 5, which consisted of 40 men and 38 women. The correlation test showed that the lower the GFR, the higher the FGF-23 level (P<0.05). No significant correlation between age, body mass index, diabetes mellitus, and hypertension with FGF-23 were detected (P>0.05). Conclusion: We found that every increase in the CKD stages and decrease of GFR, would be associated with an increase in the plasma levels of FGF-23. However, FGF-23 plasma concentration had no significant correlation with age, BMI, DM, and hypertension.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44080830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent urinary tract infections in a patient with neurogenic bladder 神经源性膀胱患者复发性尿路感染1例
Q3 Medicine Pub Date : 2022-03-04 DOI: 10.34172/npj.2022.10466
Elham Emami, A. Alikhani, Atrin Oroojeni
{"title":"Recurrent urinary tract infections in a patient with neurogenic bladder","authors":"Elham Emami, A. Alikhani, Atrin Oroojeni","doi":"10.34172/npj.2022.10466","DOIUrl":"https://doi.org/10.34172/npj.2022.10466","url":null,"abstract":"<jats:p> </jats:p>","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49134927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of hope in Iranian patients undergoing hemodialysis 接受血液透析的伊朗患者的希望预测因素
Q3 Medicine Pub Date : 2022-03-03 DOI: 10.34172/npj.2022.10415
Sakineh Moghaddam Zeabadi, M. Ranjbaran, F. Rashvand, Akram Rostampourromdasht, S. Hosseinigolafshani
Introduction: Patients undergoing hemodialysis (HD) are more vulnerable to mental, physical and spiritual disorders. These disorders may have a significant impact on their treatment process and quality of life (QoL). Given the importance of some experiences in these individuals, such as daily spiritual experiences and life expectancy, evaluating their predictive role seems necessary. Objectives: This study was conducted to determine the role of daily spiritual experiences and some demographic variables in predicting the level of hope among HD patients. Patients and Methods: In this cross-sectional study, the predictive role of daily spiritual experiences and some demographic variables in the level of hope in 262 HD patients were evaluated. The demographic variables checklist, the Daily Spiritual Experiences Scale (DSES), and the Adult Hope Scale were employed for data collection. Results: Analysis with multiple linear regression showed that the variables of gender, level of education, duration of diagnosis of renal failure, number of HD per week and daily spiritual experiences predicted 31% of the level of hope changes in HD patients. Conclusion: Nurses and provincial health care providers can help HD patients to promote their spiritual wellbeing and hope. This can be achieved by applying a holistic care approach as well as emphasizing the spiritual aspect of care and its predictive demographic variables.
简介:接受血液透析(HD)的患者更容易出现精神、身体和精神障碍。这些疾病可能对他们的治疗过程和生活质量(QoL)产生重大影响。考虑到这些人的一些经历的重要性,例如日常精神经历和预期寿命,评估他们的预测作用似乎是必要的。目的:本研究旨在确定日常精神体验和一些人口统计学变量在预测HD患者希望水平中的作用。患者和方法:在这项横断面研究中,评估了262名HD患者的日常精神体验和一些人口统计学变量对希望水平的预测作用。采用人口统计学变量清单、日常精神体验量表(DSES)和成人希望量表进行数据收集。结果:多元线性回归分析显示,性别、教育水平、肾功能衰竭诊断时间、每周HD次数和日常精神经历等变量预测了31%的HD患者的希望水平变化。结论:护士和省级卫生服务提供者可以帮助HD患者促进他们的精神健康和希望。这可以通过应用整体护理方法以及强调护理的精神方面及其预测的人口统计变量来实现。
{"title":"Predictors of hope in Iranian patients undergoing hemodialysis","authors":"Sakineh Moghaddam Zeabadi, M. Ranjbaran, F. Rashvand, Akram Rostampourromdasht, S. Hosseinigolafshani","doi":"10.34172/npj.2022.10415","DOIUrl":"https://doi.org/10.34172/npj.2022.10415","url":null,"abstract":"Introduction: Patients undergoing hemodialysis (HD) are more vulnerable to mental, physical and spiritual disorders. These disorders may have a significant impact on their treatment process and quality of life (QoL). Given the importance of some experiences in these individuals, such as daily spiritual experiences and life expectancy, evaluating their predictive role seems necessary. Objectives: This study was conducted to determine the role of daily spiritual experiences and some demographic variables in predicting the level of hope among HD patients. Patients and Methods: In this cross-sectional study, the predictive role of daily spiritual experiences and some demographic variables in the level of hope in 262 HD patients were evaluated. The demographic variables checklist, the Daily Spiritual Experiences Scale (DSES), and the Adult Hope Scale were employed for data collection. Results: Analysis with multiple linear regression showed that the variables of gender, level of education, duration of diagnosis of renal failure, number of HD per week and daily spiritual experiences predicted 31% of the level of hope changes in HD patients. Conclusion: Nurses and provincial health care providers can help HD patients to promote their spiritual wellbeing and hope. This can be achieved by applying a holistic care approach as well as emphasizing the spiritual aspect of care and its predictive demographic variables.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41394963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of aspirin in preventing thrombosis of tunneled dialysis catheters and increasing catheter survival in dialysis patients; controlled clinical trial study 阿司匹林对预防隧道式透析导管血栓形成及提高透析患者导管存续的作用对照临床试验研究
Q3 Medicine Pub Date : 2022-02-12 DOI: 10.34172/npj.2022.10464
A. Rezazadeh, S. Mohammadi Kebar, K. Isazadehfar, S. Hoseininia, Mohammadbagher Didar-Shetaban, M. Bahadoram
Introduction: Central catheters that are inserted for dialysis, often fail due to clots in the lumen or veins with a 63% prevalence. Recent studies have shown that aspirin not only acts as an antiplatelet, but also causes diminishing oxidative stress and inflammation. Objectives: The purpose of the study was to investigate the effectiveness of aspirin in preventing thrombosis in tunneled dialysis catheters in the internal jugular vein and increasing catheter survival in dialysis patients. Patients and Methods: This randomized clinical trial was conducted on 114 dialysis patients who were divided randomly into two matched groups in terms of age and gender. One group was treated with 80 mg daily aspirin regimen while other group was treated with placebo. Additionally necessary information such as age, gender, cause of renal failure, concomitant diseases like diabetes and hypertension, history of cardiovascular disease and stroke, peripheral vascular diseases, history of statin use and history of anti-thrombotic drugs were obtained of patients by checklists. Results: The incidence of venous thrombosis in the aspirin group was 3.5% and in the control group was 14%. The difference was statistically significant (P=0.001). Conclusion: Results showed that administration of aspirin can be effective in increasing catheter survival in dialysis patients and preventing thrombosis of catheters especially in diabetics and male patients. Trial Registration: The trial was approved by the Iranian registry of clinical trials (identifier: IRCT20181128041785N1; https://www.irct.ir/trial/35610, ethical code; IR.ARUMS.REC.1397.190).
引言:插入透析的中心导管通常因管腔或静脉中的血栓而失败,发生率为63%。最近的研究表明,阿司匹林不仅具有抗血小板作用,还能减少氧化应激和炎症。目的:本研究旨在探讨阿司匹林在预防颈内静脉隧道透析导管血栓形成和提高透析患者导管存活率方面的有效性。患者和方法:本随机临床试验对114名透析患者进行,他们按年龄和性别随机分为两组。一组接受每日80mg阿司匹林方案治疗,另一组接受安慰剂治疗。此外,还通过检查表获得了患者的年龄、性别、肾功能衰竭原因、糖尿病和高血压等伴随疾病、心血管疾病和中风史、外周血管疾病史、他汀类药物使用史和抗血栓药物史等必要信息。结果:阿司匹林组静脉血栓形成的发生率为3.5%,对照组为14%。结论:阿司匹林可有效提高透析患者的导管存活率,预防导管血栓形成,尤其是糖尿病患者和男性患者。试验注册:该试验由伊朗临床试验注册中心批准(标识符:IRCT20181128041785N1;https://www.irct.ir/trial/35610,道德规范;IR.ARUMS.REC.1397.190)。
{"title":"Effect of aspirin in preventing thrombosis of tunneled dialysis catheters and increasing catheter survival in dialysis patients; controlled clinical trial study","authors":"A. Rezazadeh, S. Mohammadi Kebar, K. Isazadehfar, S. Hoseininia, Mohammadbagher Didar-Shetaban, M. Bahadoram","doi":"10.34172/npj.2022.10464","DOIUrl":"https://doi.org/10.34172/npj.2022.10464","url":null,"abstract":"Introduction: Central catheters that are inserted for dialysis, often fail due to clots in the lumen or veins with a 63% prevalence. Recent studies have shown that aspirin not only acts as an antiplatelet, but also causes diminishing oxidative stress and inflammation. Objectives: The purpose of the study was to investigate the effectiveness of aspirin in preventing thrombosis in tunneled dialysis catheters in the internal jugular vein and increasing catheter survival in dialysis patients. Patients and Methods: This randomized clinical trial was conducted on 114 dialysis patients who were divided randomly into two matched groups in terms of age and gender. One group was treated with 80 mg daily aspirin regimen while other group was treated with placebo. Additionally necessary information such as age, gender, cause of renal failure, concomitant diseases like diabetes and hypertension, history of cardiovascular disease and stroke, peripheral vascular diseases, history of statin use and history of anti-thrombotic drugs were obtained of patients by checklists. Results: The incidence of venous thrombosis in the aspirin group was 3.5% and in the control group was 14%. The difference was statistically significant (P=0.001). Conclusion: Results showed that administration of aspirin can be effective in increasing catheter survival in dialysis patients and preventing thrombosis of catheters especially in diabetics and male patients. Trial Registration: The trial was approved by the Iranian registry of clinical trials (identifier: IRCT20181128041785N1; https://www.irct.ir/trial/35610, ethical code; IR.ARUMS.REC.1397.190).","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43778948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ameliorative effects of pirfenidone in chronic kidney disease 吡非尼酮对慢性肾病的改善作用
Q3 Medicine Pub Date : 2022-01-10 DOI: 10.34172/npj.2022.10458
Samad Ghodrati, Yeganeh Ragati Haghi, J. Baharani, Akshaya Joseph, Niloufar Alimohammadi, Farzad Koosha, Leila Mostafavi, A. Pezeshgi
Renal fibrosis is the hallmark of advanced chronic kidney disease (CKD), which is characterized by excessive accumulation of extracellular matrix (ECM) proteins and plays a central role in the pathogenesis and progression of CKD to end-stage renal disease (ESRD). The molecular and cellular substances of kidney fibrosis include growth factors, such as fibroblast growth factor (FGF), transforming growth factor beta (TGF-β) and platelet-derived growth factor (PDGF), alongside cytokines (like interleukin-1b) and metalloproteinases. Therefore, these factors can be evaluated as possible targets for anti-fibrotic agents. Among the mediators of fibrosis, TGF-β is the dominant facilitator of renal fibrosis that induces ECM construction and accumulation. Numerous studies have focused on the inhibition of TGF-β and its downstream targets for the treatment of renal disease. Abolition of TGF-β mRNA expression was found to be the mechanism of anti-fibrotic drug, pirfenidone, in the heart and kidneys of diabetic rats. Various investigations have shown the impact of pirfenidone in diminishing kidney fibrosis, with studies containing patients diagnosed with subtotal nephrectomy, diabetic kidney disease and unilateral ureteral obstruction (UUO), administered drugs such as cyclosporine, tacrolimus, doxorubicin and vanadate. Several therapeutic drugs for fibrosis reduce only one of the oxidative, inflammatory or profibrogenic markers, while pirfenidone targets all three of these markers and therefore, seems to be a particularly valuable drug.
肾脏纤维化是晚期慢性肾脏疾病(CKD)的标志,其特征是细胞外基质(ECM)蛋白的过度积累,在CKD的发病和发展到终末期肾脏疾病(ESRD)中起着核心作用。肾纤维化的分子和细胞物质包括生长因子,如成纤维细胞生长因子(FGF)、转化生长因子β (TGF-β)和血小板衍生生长因子(PDGF),以及细胞因子(如白细胞介素-1b)和金属蛋白酶。因此,这些因素可以作为抗纤维化药物的可能靶点。在纤维化介质中,TGF-β是肾纤维化的主要促进因子,可诱导ECM的构建和积累。大量的研究集中在抑制TGF-β及其下游靶点治疗肾脏疾病。发现抗纤维化药物吡非尼酮在糖尿病大鼠心脏和肾脏中抑制TGF-β mRNA的表达是其作用机制。各种研究表明吡非尼酮在减少肾纤维化方面的作用,研究包括诊断为肾大部切除术、糖尿病肾病和单侧输尿管梗阻(UUO)的患者,给予环孢素、他克莫司、阿霉素和钒酸盐等药物。几种治疗纤维化的药物只能减少氧化、炎症或纤维化前标志物中的一种,而吡非尼酮针对所有这三种标志物,因此似乎是一种特别有价值的药物。
{"title":"Ameliorative effects of pirfenidone in chronic kidney disease","authors":"Samad Ghodrati, Yeganeh Ragati Haghi, J. Baharani, Akshaya Joseph, Niloufar Alimohammadi, Farzad Koosha, Leila Mostafavi, A. Pezeshgi","doi":"10.34172/npj.2022.10458","DOIUrl":"https://doi.org/10.34172/npj.2022.10458","url":null,"abstract":"Renal fibrosis is the hallmark of advanced chronic kidney disease (CKD), which is characterized by excessive accumulation of extracellular matrix (ECM) proteins and plays a central role in the pathogenesis and progression of CKD to end-stage renal disease (ESRD). The molecular and cellular substances of kidney fibrosis include growth factors, such as fibroblast growth factor (FGF), transforming growth factor beta (TGF-β) and platelet-derived growth factor (PDGF), alongside cytokines (like interleukin-1b) and metalloproteinases. Therefore, these factors can be evaluated as possible targets for anti-fibrotic agents. Among the mediators of fibrosis, TGF-β is the dominant facilitator of renal fibrosis that induces ECM construction and accumulation. Numerous studies have focused on the inhibition of TGF-β and its downstream targets for the treatment of renal disease. Abolition of TGF-β mRNA expression was found to be the mechanism of anti-fibrotic drug, pirfenidone, in the heart and kidneys of diabetic rats. Various investigations have shown the impact of pirfenidone in diminishing kidney fibrosis, with studies containing patients diagnosed with subtotal nephrectomy, diabetic kidney disease and unilateral ureteral obstruction (UUO), administered drugs such as cyclosporine, tacrolimus, doxorubicin and vanadate. Several therapeutic drugs for fibrosis reduce only one of the oxidative, inflammatory or profibrogenic markers, while pirfenidone targets all three of these markers and therefore, seems to be a particularly valuable drug.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48946571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acquired hemophilia in a patient with SARS-CoV-2 infection; a case report 1例SARS-CoV-2感染患者的获得性血友病病例报告
Q3 Medicine Pub Date : 2021-12-18 DOI: 10.34172/npj.2022.10453
A. Hajigholami, Hourieh Ansari, S. Ansari, S. Hassanzadeh
Acquired hemophilia (AH) is a potentially life-threatening hemorrhagic disorder. We report the second confirmed case of COVID-19-associated AH in a 45-year-old female which, unfortunately, expired as her treatment failed. She presented to the emergency department with abnormal bleeding and spontaneous hemoptysis about ten days after a removal surgery of her epiglottis tumor. Aggregation tests, such as partial thromboplastin time (PTT), are recommended in patients with COVID-19 infection that have bleeding episodes.
获得性血友病(AH)是一种潜在威胁生命的出血性疾病。我们报告第二例与covid -19相关的AH确诊病例,患者为一名45岁女性,不幸的是,由于治疗失败而死亡。她在会厌肿瘤切除手术后约10天因异常出血和自发性咯血就诊于急诊科。对于有出血发作的COVID-19感染患者,建议进行聚集试验,如部分凝血活素时间(PTT)。
{"title":"Acquired hemophilia in a patient with SARS-CoV-2 infection; a case report","authors":"A. Hajigholami, Hourieh Ansari, S. Ansari, S. Hassanzadeh","doi":"10.34172/npj.2022.10453","DOIUrl":"https://doi.org/10.34172/npj.2022.10453","url":null,"abstract":"Acquired hemophilia (AH) is a potentially life-threatening hemorrhagic disorder. We report the second confirmed case of COVID-19-associated AH in a 45-year-old female which, unfortunately, expired as her treatment failed. She presented to the emergency department with abnormal bleeding and spontaneous hemoptysis about ten days after a removal surgery of her epiglottis tumor. Aggregation tests, such as partial thromboplastin time (PTT), are recommended in patients with COVID-19 infection that have bleeding episodes.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48130871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Nephropharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1